Continuous Glucose Monitoring in Hospitalized Patients with Diabetes Mellitus
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Jacksonville, Florida: 20-008826
NCT ID: NCT04653454
About this study
The purpose of this study is to determine if patient’s own Continuous Glucose Monitoring (CGMs) worn in the non-ICU hospital setting have adequate accuracy for blood glucose monitoring when compared to point-of-care capillary glucose measurement, and to determine if alerts given by CGMs worn in the non-ICU hospital would prevent episodes of hyperglycemia and hypoglycemia.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Patients with Type 1 or 2 Diabetes Mellitus,
- Patients 18 years of age or older,
- Patients admitted under medical or surgical services.
- Patients treated with diet alone, insulin (SQ, insulin pump) or oral hypoglycemic medications.
- Have their own Continuous Glucose Monitoring (CGM) monitor present on admission or able to be placed after admission.
Exclusion Criteria:
- Individuals under 18 years of age.
- COVID-19 infection.
- Infection of the skin at the CGM site requiring removal of the sensor.
- Patients with altered Mental Status.
- Patients unable to scan their flash CGMs at least every 8 hours.
- Inability to provide written consent.
- Hospitalized for less than 24 hours.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Jacksonville, Fla.
Mayo Clinic principal investigator Adrian Dumitrascu, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available